#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Shprintzen-Goldberg syndrome Fatty acid oxidation disorder Squamous cell carcinoma of the vulva Follicle centre lymphoma follicular grade I, II – III Congenital nephrogenic diabetes insipidus Enteritis Rectal cancer Hodgkin's disease Mycobacterium abscessus infection Arrhythmogenic right ventricular dysplasia Mucopolysaccharidosis III Peritoneal mesothelioma malignant Hyperoxaluria Herpes simplex Aspergillus infection More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Diagnostics Sjogren’s syndrome – Basic Information Glomerulonephritis rapidly progressive – Treatment Factor IX deficiency – Trials in Disease Indolent systemic mastocytosis – Life with Disease Pulmonary sarcoidosis – Diagnostics Primary mediastinal large B-cell lymphoma – Trials in Disease Activated PI3 kinase delta syndrome Leukoencephalopathy – Diagnostics Castleman’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alpelisib Valiltramiprosate L-Lysine Hydrochloride Syn2 Ginisortamab Capivasertib Patisiran Chlorhexidine Dihydrochloride DNL593 Flucloxacillin ORG-129 Zofenopril Calcium Tuvusertib Emicizumab Bgb-15025 Citrate GOLD SODIUM THIOSULFATE Diltiazem Hydrochloride Buclizine Hydrochloride Cpk850 Pariglasgene Brecaparvovec More therapies…

    Learn about Your Condition

    Intestinal ischaemia Pyoderma Colitis Glaucoma Hypomagnesaemia Fallopian tube cancer stage IV Follicular lymphoma Facial paresis Gender dysphoria Lung adenocarcinoma Infection Lymphocytic lymphoma Peripheral artery stenosis Diverticulitis Gingival bleeding More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Otorhinolaryngologic Diseases

  • Study on Reducing Morphine Use After Throat and Neck Cancer Surgery Using Ropivacaine and Sodium Chloride for Patients Undergoing Cancer Surgery

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine
    • Sodium Chloride
    France

  • Study on Botulinum Toxin A for Tinnitus in Patients with Bruxism or Jaw Muscle Pain

    Recruiting

    3 1 1
    Investigated Diseases:
    • Tinnitus
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Norway

  • Study on Reducing Biologic Treatments Mepolizumab and Dupilumab for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Dupilumab
    Denmark

  • Study of Pembrolizumab for Patients with High-Risk Thyroid Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study of Tezepelumab effects on airway barrier function in patients with severe asthma, with or without chronic rhinosinusitis with nasal polyps

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    • Asthma
    Investigated Drugs:
    • Tezepelumab
    Austria

  • Study on the Effects of Intracochlear Triamcinolone Acetonide for Patients with Persistent Sudden Sensorineural Hearing Loss After Unsuccessful Conservative Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Deafness
    • Deafness neurosensory
    Investigated Drugs:
    • Triamcinolone Acetonide
    Austria
Previous Page
1 2 3 4 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!